Effectiveness for Interventions to Minimize Surgical Site Infections
Developing Evidence of Effectiveness for Adjuvant Interventions Designed to Minimize Surgical Site Infections
1 other identifier
interventional
120
1 country
1
Brief Summary
The purpose of this study is to evaluate two different simple and inexpensive extra treatments during colorectal surgeries to see if this will reduce the rate of post operative infections
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2010
CompletedFirst Posted
Study publicly available on registry
June 30, 2010
CompletedStudy Start
First participant enrolled
August 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedNovember 4, 2011
November 1, 2011
2.1 years
June 29, 2010
November 3, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Infection rate in colorectal surgeries in each of two treatment arms as compared to historic controls
pilot study to evaluate 1. pressurized irrigation of the superficial surgical wound after fascial closure in 40 patients and 2. subcutaneous gentamicin into the surgical area prior to initial incision in 40 patients and compare rates of surgical site infections after 30 days to historic controls.
30 days after surgery
Study Arms (2)
Pressurized irrigation
EXPERIMENTALfirst group-After closure of patients abdominal wall fascia, Hydrostatic irrigation with 3 liters of normal saline with Simpulse Solo irrigation system (Davol) at less than 15PSI will be applied to subcutaneous tissues prior to closure
Sub Q Antibiotic
EXPERIMENTALsecond group of patients will receive 2mg/lg of gentamicin in 20 ml of sterile saline injected into the superficial tissues above the ABD wall fascia prior to initial incision
Interventions
2mg/kg of gentamicin in 20 ml of sterile saline up to max dose of 120mg injected above the abdominal wall fascia- the length of the incision will be marked and injection made with intent being to evenly distribute the volume of injection in the subcutaneous tissues in immediate vicinity of and prior to the initial incision- analogous to the technique employed when using local anesthetic
Eligibility Criteria
You may qualify if:
- VA patients getting transabdominal,elective colorectal procedures
- willing and capable of giving self informed consent
You may not qualify if:
- patients unable to give informed consent
- emergency colorectal procedures
- transanal procedures
- patients who have contaminated or dirty wounds that would preclude attempts at skin closure at the conclusion of the procedure
- patients undergoing appendectomy
- patients undergoing intraabdominal procedures not including surgical resection of the colon or rectum (ie.procedures involving small bowel , stomach)
- patients with pre/op creatinine clearance less than 20ml/min
- patients with known allergy or hypersensitivity to gentamicin
- patients that have received gentamicin within 2 weeks of potential study date
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VANTXHCS
Dallas, Texas, 75216, United States
Related Publications (1)
Dineen SP, Pham TH, Murray BW, Parker BJ, Hartless K, Anthony T, Huerta S. Feasibility of subcutaneous gentamicin and pressurized irrigation as adjuvant strategies to reduce surgical site infection in colorectal surgery: results of a pilot study. Am Surg. 2015 Jun;81(6):573-9.
PMID: 26031269DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Sean Dineen, MD
VANTXHCS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
June 29, 2010
First Posted
June 30, 2010
Study Start
August 1, 2010
Primary Completion
September 1, 2012
Study Completion
December 1, 2012
Last Updated
November 4, 2011
Record last verified: 2011-11